Due to these complexities, further research is essential to delineate specific obesity phenotypes, clarify leptin’s mechanistic role, and evaluate the potential of leptin sensitizers or other targeted interventions to address obesity-related complications in COPD management [273]. This evidence concerns the gene LEP and Obesity.